SUSTAINED VIROLOGIC RESPONSE 12 WEEKS POST-TREATMENT WITH INTERFERON-FREE REGIMENS OF ABT-450/R, ABT-267, ABT-333, AND RIBAVIRIN IN CHRONIC HCV GENOTYPE 1 DIFFICULT-TO-TREAT PATIENT SUBGROUPS

Maribel Rodriguez-Torres  1     Frederick Nunes  2     Daniel E. Cohen  3     Christal Marincic  3     Amit Khatri  3     Tami Pilot-Matias  3     Thomas Podsadecki  3     Barry Bernstein  3    
1 Fundación de Investigación
2 PHGI Assoc. Ltd.
3 AbbVie

Conference
UEG Week 2013

Citation
United European Gastroenterology Journal; 2013: 1 (Supplement 1) A1


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing